17,000 sf state-of-the-art research Cannabis Cultivation Facility
Customized Derivative Production
Contract R&D Operations
Leading Edge Analytical Services & Research
Analytical Services:
Consulting Services:
Research and Development:
Supra is licensed by Health Canada to conduct research, provide chemical analysis and produce extracts and derivatives of cannabis materials in addition to offering analytical services to the wider natural health product sector. Our corporate mandate is to provide scientific leadership and to support the production of the highest quality herbal medicinal products on the market.
Facilities Build Out, Licensing & Production (under LOI)
Phase 1 ($2.5M all-in capital cost):
Phase 2 ($60\sf all-in capital cost):
Phase 3 ($60\sf all-in capital cost):
Additional Expansion Capability Available
MKV Ventures 1, LLC (“MKV”), a wholly-owned subsidiary of MKHS, LLC, has engaged VGW to help manage and fund expansion on its 9.5 acre operating site:
Featured {{ article.headline | getDecodedUnicode }} • {{ article.symbol }} • {{ article.date }} {{ article.time }}